Price Alert

Catalyst Pharmaceuticals ... (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

20.23

0.16 (0.80%)

At close: Aug 15, 2025, 3:59 PM

20.15

-0.37%

After-hours: Aug 15, 2025, 07:54 PM EDT

Catalyst Pharmaceuticals Statistics

Share Statistics

Catalyst Pharmaceuticals has 122.39M shares outstanding. The number of shares has increased by 2.77% in one year.

Shares Outstanding	122.39M
Shares Change (YoY)	2.77%
Shares Change (QoQ)	0.43%
Owned by Institutions (%)	80.8%
Shares Floating	111.54M
Failed to Deliver (FTD) Shares	200
FTD / Avg. Volume	0.02%

Short Selling Information

The latest short interest is 8.92M, so 7.31% of the outstanding shares have been sold short.

Short Interest	8.92M
Short % of Shares Out	7.31%
Short % of Float	9.35%
Short Ratio (days to cover)	6.89

Valuation Ratios

The PE ratio is 15.08 and the forward PE ratio is 11.26. Catalyst Pharmaceuticals's PEG ratio is 0.14.

PE Ratio	15.08
Forward PE	11.26
PS Ratio	5.03
Forward PS	4
PB Ratio	3.4
P/FCF Ratio	10.33
PEG Ratio	0.14

Financial Ratio History

Enterprise Valuation

Catalyst Pharmaceuticals has an Enterprise Value (EV) of 1.96B.

EV / Sales	3.98
EV / EBITDA	8.41
EV / EBIT	8.16
EV / FCF	8.18

Financial Position

The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.

Current Ratio	5.17
Quick Ratio	5.01
Debt / Equity	0
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	0

Financial Efficiency

Return on Equity is 22.52% and Return on Invested Capital is 20.22%.

Return on Equity	22.52%
Return on Assets	19.25%
Return on Invested Capital	20.22%
Revenue Per Employee	$2.72M
Profits Per Employee	$905.46K
Employee Count	181
Asset Turnover	0.58
Inventory Turnover	3.52

Taxes

Income Tax	52.37M
Effective Tax Rate	24.22%

Stock Price Statistics

The stock price has increased by 2.02% in the last 52 weeks. The beta is 0.7, so Catalyst Pharmaceuticals's price volatility has been higher than the market average.

Beta	0.7
52-Week Price Change	2.02%
50-Day Moving Average	22.36
200-Day Moving Average	22.49
Relative Strength Index (RSI)	36.64
Average Volume (20 Days)	1,317,583

Income Statement

In the last 12 months, Catalyst Pharmaceuticals had revenue of 491.73M and earned 163.89M in profits. Earnings per share was 1.38.

Revenue	491.73M
Gross Profit	422.89M
Operating Income	195.12M
Net Income	163.89M
EBITDA	232.9M
EBIT	195.12M
Earnings Per Share (EPS)	1.38

Full Income Statement

Balance Sheet

The company has 517.55M in cash and 3.19M in debt, giving a net cash position of 514.37M.

Cash & Cash Equivalents	517.55M
Total Debt	3.19M
Net Cash	514.37M
Retained Earnings	285.16M
Total Assets	971.91M
Working Capital	645.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 239.81M and capital expenditures -556K, giving a free cash flow of 239.25M.

Operating Cash Flow	239.81M
Capital Expenditures	-556K
Free Cash Flow	239.25M
FCF Per Share	2.02

Full Cash Flow Statement

Margins

Gross margin is 86%, with operating and profit margins of 39.68% and 33.33%.

Gross Margin	86%
Operating Margin	39.68%
Pretax Margin	43.98%
Profit Margin	33.33%
EBITDA Margin	47.36%
EBIT Margin	39.68%
FCF Margin	48.65%

Dividends & Yields

CPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	6.63%
FCF Yield	9.68%

Dividend Details

Analyst Forecast

The average price target for CPRX is $33, which is 67.6% higher than the current price. The consensus rating is "Buy".

Price Target	$33
Price Target Difference	67.6%
Analyst Consensus	Buy
Analyst Count	5

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$19.18
Lynch Upside	-2.59%
Graham Number	13.83
Graham Upside	-29.76%

Scores

Altman Z-Score	15.17
Piotroski F-Score	6